Scientists all over the world have constantly been dreading about the cure for HIV and AIDS diseases. As one of the most concerning diseases, clinical trials for the said illnesses are being performed to finally come up with a definite solution to the problem. Consequently, a team of researchers have recently found that by creating a disruption to a certain protein type can actually play a great role in fighting the long dreaded disease as it has been seen to result to the immune response against the viral infections brought by HIV.
Blocking Type I Interferon Protein: The Answer To HIV?
According To reports revealed by Yibada, a recent cure update has revealed a promising step towards a positive in response against viral infections through properly understanding certain protein type. The study, led by researchers from UCLA has found that by blocking type I interferon, a type of protein used for the restoration of immune function and speeding up viral suppression during treatment with anti-viral drugs have been observed. The experts claimed that interferon has the ability to fight HIV by mediating the action of both of the known restriction factors, which is why it has been previously held that the more of the said protein the better, contrary to the previous proposition of some health experts that it doesn't do any good.
Furthermore, in one of his statements reported by Punjab News Express, senior author of the study Scott Kitchen, who is also an Associate Professor at David Geffen School of Medicine, University of California, Los Angeles has revealed that the type of interferon that is being produced during chronic stages of HIV infection has adverse impacts on the body's ability to fight off HIV and other types of infection or cancer and could in fact be contributing to accelerated HIV disease. In conducting their study, the researchers had "Humanized mice," which have had their immune systems replaced with human immune system cells, thymus tissue and bone marrow. As a result, they eventually were able to cure HIV-infected mice with antibodies that blocked Type-I interferons. Ultimately, Prof. Kitchen and his team has concluded that by blocking this immune response against the virus had beneficial effects in lowering the amounts of virus and increasing the ability of the immune response to clear out the virus.
